Entity Common Stock, Shares Outstanding of COLLEGIUM PHARMACEUTICAL, INC from 12 Jun 2015 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
COLLEGIUM PHARMACEUTICAL, INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Jun 2015 to 31 Oct 2025.
  • COLLEGIUM PHARMACEUTICAL, INC Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 31,610,976, a 2% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

COLLEGIUM PHARMACEUTICAL, INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 31,610,976 -639,260 -2% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 31,502,127 -711,624 -2.2% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 32,142,192 -573,130 -1.8% 30 Apr 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 31,485,523 -474,305 -1.5% 31 Jan 2025 10-K 27 Feb 2025 2024 FY
Q3 2024 32,250,236 -360,637 -1.1% 31 Oct 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 32,213,751 -2,520,305 -7.3% 31 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 32,715,322 -1,879,438 -5.4% 30 Apr 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 31,959,828 -2,106,740 -6.2% 31 Jan 2024 10-K 22 Feb 2024 2023 FY
Q3 2023 32,610,873 -961,050 -2.9% 31 Oct 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 34,734,056 +607,851 +1.8% 31 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 34,594,760 +621,425 +1.8% 30 Apr 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 34,066,568 +688,780 +2.1% 31 Jan 2023 10-K 23 Feb 2023 2022 FY
Q3 2022 33,571,923 -996,786 -2.9% 31 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 34,126,205 -1,438,260 -4% 31 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 33,973,335 -1,274,283 -3.6% 30 Apr 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 33,377,788 -1,378,523 -4% 31 Jan 2022 10-K 24 Feb 2022 2021 FY
Q3 2021 34,568,709 -13,615 -0.04% 31 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 35,564,465 +1,038,815 +3% 31 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 35,247,618 +911,586 +2.7% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 34,756,311 +705,449 +2.1% 31 Jan 2021 10-K 25 Feb 2021 2020 FY
Q3 2020 34,582,324 +1,055,247 +3.1% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 34,525,650 +1,055,120 +3.2% 31 Jul 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 34,336,032 +949,360 +2.8% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 34,050,862 +745,851 +2.2% 31 Jan 2020 10-K 27 Feb 2020 2019 FY
Q3 2019 33,527,077 +279,592 +0.84% 31 Oct 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 33,470,530 +248,826 +0.75% 31 Jul 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 33,386,672 +342,622 +1% 30 Apr 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 33,305,011 31 Jan 2019 10-K 27 Feb 2019 2018 FY
Q3 2018 33,247,485 +685,208 +2.1% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 33,221,704 +3,654,729 +12% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 33,044,050 +3,585,493 +12% 30 Apr 2018 10-Q 09 May 2018 2018 Q1
Q3 2017 32,562,277 +3,951,726 +14% 31 Oct 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 29,566,975 +6,038,535 +26% 28 Jul 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 29,458,557 +5,951,210 +25% 30 Apr 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 28,610,551 +7,921,637 +38% 31 Oct 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 23,528,440 +2,862,843 +14% 30 Jul 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 23,507,347 04 Mar 2016 10-K 18 Mar 2016 2015 FY
Q3 2015 20,688,914 31 Oct 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 20,665,597 12 Jun 2015 10-Q/A 17 Jul 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.